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Objective: To evaluate the effect of the Aging Brain Care (ABC) Medical Home program’s 
depression module on patients’ depression severity measurement over time.
Design: Retrospective chart review.
Setting: Public hospital system.
Participants: Patients enrolled in the ABC Medical Home program between October 1, 2012 
and March 31, 2014.
Methods: The response of 773 enrolled patients who had multiple patient health questionnaire-9 
(PHQ-9) scores recorded in the ABC Medical Home program’s depression care protocol was 
evaluated. Repeatedly measured PHQ-9 change scores were the dependent variables in the mixed 
effects models, and demographic and comorbid medical conditions were tested as potential 
independent variables while including random effects for time and intercept.
Results: Among those patients with baseline PHQ-9 scores .10, there was a significant decrease 
in PHQ-9 scores over time (P,0.001); however, the effect differed by gender (P=0.015). On 
average, women’s scores (4.5 point drop at 1 month) improved faster than men’s scores (1 point 
drop at 1 month). Moreover, both men and women had a predicted drop of 7 points (.50% 
decline from baseline) on the PHQ-9 at 6 months. 
Conclusion: These analyses demonstrate evidence for the sustained effectiveness of the ABC 
Medical Home program at inducing depression remission outcomes while employing clinical 
staff who required less formal training than earlier clinical trials.
Keywords: geriatrics, care coordination, Medicare
Introduction
Depression among older adults is common, a major cause of disability, and is associ-
ated with increased mortality.1–3 The rate of major depression in community-dwelling 
older adults is ~2%,4 although the rates are higher among hospitalized individuals.5 
Minor depression is more common still with rates varying from 9.8% among seniors 
dwelling in the community to 14%–25% among older adults who are hospitalized.4,5 
Depression is associated with costs that accrue to society, families, and individuals 
by a variety of mechanisms, including lost productivity, time away from work, costs 
for the treatment of depression in patients, and increased costs for treating comorbid 
conditions in patients.3,6 Due to its prevalence, burden, and associated costs, depres-
sion has become a major target condition for health programs that wish to improve 
the care of older adults.
However, psychiatrists with specialized training in geriatric mental health to treat 
these older adults are in short supply.7 Indeed, the majority of mental health care in the 
USA is provided not by mental health professionals but by general medical care provid-
ers and is considered inadequate.8 Interventions that support primary care physicians in 
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providing effective care to older adults with depression have 
been developed and shown to be effective in a large, multisite 
randomized controlled trial.9 In translating the findings from 
randomized controlled trials to active clinical practice, adapta-
tions are frequently needed.10 In 2008, the Improving Mood – 
Promoting Access to Collaborative Treatment (IMPACT) 
model of depression care was successfully implemented in 
the Healthy Aging Brain Center clinical venue with positive 
results.11 Though effective, this model was limited by its 
requirement that patients present to the clinic for care and 
was not considered scalable due to limitations in the number 
of available care providers. As a result, in 2010 the Aging 
Brain Care (ABC) Medical Home program was developed, 
which employs a mobile and versatile workforce that can 
meet patients in their home environment.12,13
This investigation evaluated the effect of the ABC 
Medical Home program’s depression module on patients’ 
depression severity measurement over time. Specifically, 
the change in patient health questionnaire-9 (PHQ-9) score 
over time was investigated, stratified by the initial score. 
Additionally, clinical predictors were identified for response 
to the program’s depression intervention. 
Methods
study design and setting
This was an analysis of depression care data from the ABC 
Medical Home, a program designed to augment the care that 
is provided by primary care physicians to older adults with 
late-life depression and/or dementia. The design and evolu-
tion of the program have been described previously.12–14 The 
program is notable for several features that are reviewed 
briefly here that differentiate it from other clinical care 
programs. First, the majority of care in the ABC Medical 
Home is provided by care coordinator assistants (CCAs), 
persons selected for their ability to communicate and desire 
to work with older adults.15,16 These CCAs have primarily 
high school and 2-year college education, rather than more 
advanced degrees, and so represent the program’s strategy 
to create a more scalable geriatric care workforce to meet 
the care needs of the nation’s growing population of seniors. 
CCAs are supervised by a team of nurses and social workers, 
skilled in the care of older adults, and overseen by a geriatric 
medical director. Second, the program has provided training 
in the IMPACT model of depression care and in advanced 
dementia care practices to the CCAs, nurses, and social 
workers. IMPACT is a collaborative care model of depres-
sion care that utilizes care managers to support primary care 
providers in adopting a systematic approach to the treatment 
of patients’ depressive symptoms.9 CCAs, social workers, 
and nurses received training in the principles of the IMPACT 
model of care from the University of Washington’s AIMS 
Center. In line with this training, the team members practice 
measurement-based care and use validated instruments, the 
PHQ-9 for depression and the Healthy Aging Brain Center 
Monitor (HABC-M) for dementia, to track patient response 
to clinical interventions.17,18 Finally, the team members record 
PHQ-9 and HABC-M scores of the patients in the electronic 
medical record-ABC, the tracking software of the program.19 
In this manner, they can easily monitor responses of indi-
vidual patients to the interventions longitudinally as well as 
the overall health of their assigned panel of patients.
Results of this program that was centered at Eskenazi 
Health (formerly Wishard Health Services), a safety-net, 
urban, public hospital, 10 community health centers located 
in Indianapolis, Indiana, and in the homes of patients who 
receive medical care at these facilities are presented here. As 
described previously,13 ABC Medical Home team members 
provide services to patients and their caregivers in a variety 
of settings in order to maximize access. Ethical approval 
and patient written informed consent for participation in the 
program and analysis of the program’s data were deemed 
not necessary by the Indiana University institutional review 
board as this work was determined to not constitute human 
subjects research.
Program implementation
The depression program of the ABC Medical Home is based 
on the IMPACT model of depression care.9 The identifica-
tion and enrollment of patients and the ABC Medical Home 
depression intervention have been described previously.13 All 
patients in the program were prospectively identified prior to 
enrollment in the program as having diagnoses of dementia, 
depression, or both, using International Classification of 
Disease, Ninth Revision codes of either condition and a visit 
to an Eskenazi Health care provider in the prior 24 months. 
Briefly, the depression intervention can be divided into 
three phases. During the first phase, the CCA initially visits 
the patient to stage their cognitive status using the PHQ-9, 
mini-mental state exam, and HABC-M. Following this 
visit, the CCA meets the team nurse and social worker to 
develop an individualized care plan for the patient, including 
referral for more extensive evaluation by memory care and 
mental health care specialists if deemed necessary. After 
this initial visit, a follow-up patient visit happens within 
2–4 weeks to review the initial care plan and provide access 
to appropriate educational and community health resources. 
Patients with low-level depressive symptoms (PHQ-9 ,10) 
are offered behavioral activation and relapse prevention 
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activities. Patients with symptoms consistent with major 
depression (PHQ-9 $10) are offered problem-solving 
therapy by the team nurses and social workers. If patients 
are believed to be candidates for initiation or adjustment of 
pharmacologic antidepressant therapy, they are referred back 
to their primary care physicians. In the follow-up phase of 
the program, patient visits are organized every month for the 
first 3 months and then every 3 months thereafter. At each 
visit, depression symptoms of the patients are measured 
using the PHQ-9. Adjustments are made to the patient’s plan 
of care by the CCA, nurse, and social worker based on the 
patient’s scores on the PHQ-9 and other clinical information. 
During the acute care transition phase of the program, the 
ABC Medical Home team contacts inpatient hospital care 
providers if the patient is hospitalized and shares relevant 
physical, cognitive, and mental health background informa-
tion to aid in the patient’s care. During the patient’s hospital 
discharge, the patient’s care coordinator seeks to meet the 
patient within 72 h to perform medication reconciliation and 
coordinate post-discharge care planning.
statistical analysis
In this analysis, the responses of patients enrolled in the ABC 
Medical Home depression care protocol were evaluated. 
First, chi-square tests and Wilcoxon rank sum tests were 
used to compare the demographics and clinical characteris-
tics, including comorbidities, of patients who had multiple 
PHQ-9 scores and those who had only one PHQ-9 score 
recorded in their clinical record. Next, chi-square tests were 
utilized to compare demographics and comorbid conditions in 
patients with multiple PHQ-9 evaluations divided into three 
groups by baseline PHQ-9 scores (0–4, 5–9, or $10). Mixed 
effects models were used separately for the three groups 
of patients based on their baseline PHQ-9 scores. Repeat-
edly measured PHQ-9 change scores were the dependent 
variables in the mixed effects models, and the demographic 
and comorbid medical conditions were tested as potential 
independent variables while including random effects for 
time and intercept. Comparable results were obtained when 
running similar models using PHQ-9 scores as the outcome 
while adjusting for the baseline PHQ-9 score. Since the 
results were similar, those using the change score are only 
reported. All the analyses were performed using SAS v9.3 
and P,0.05 was considered statistically significant. 
Results
Between October 1, 2012 and March 31, 2014, 1,621 patients 
were enrolled in the ABC Medical Home program’s registry 
and had their clinical data registered in the electronic medical 
record for the ABC Medical Home program at Eskenazi 
Health. During this 18-month period, 871 (54%) patients 
had at least one PHQ-9 assessment recorded. Seven hundred 
and seventy-three of these 871 patients (89%) had at least 
one additional PHQ-9 score recorded on a subsequent visit. 
Table 1 shows the demographic and clinical characteristics of 
patients who either had or did not have a subsequent PHQ-9 
score recorded after their baseline PHQ-9 score. Patients who 
subsequently had PHQ-9 scores recorded in their chart were 
younger, had a higher proportion of depression recorded in 
their chart as a medical comorbidity, had higher baseline 
PHQ-9 scores, and had lower rates of either congestive heart 
failure (CHF) or dementia. 
Table 2 shows the association of baseline PHQ-9 scores 
by strata with demographics and comorbid conditions of 
the 773 patients with subsequent PHQ-9 scores recorded. 
Women tended to have higher baseline PHQ-9 scores, as 
did patients of White race and younger age. Patients with 
chronic obstructive pulmonary disease, depression recorded 
in their chart, and taking antidepressants also tended to have 
higher incidences of baseline PHQ-9 scores $10. The vast 
majority of visits in this program were performed by CCAs, 
both at the initial visit and at subsequent visits. Nurses and 
social workers participated in return visits more frequently 
when patients had higher initial PHQ-9 scores.
Table 1 Association of PhQ-9 follow-up status with demographics 
and comorbid conditions
Characteristic PHQ-9 on 
additional 
visits (n=773)
No PHQ-9 
on additional 
visits (n=98)
P-value
Female (%) 79.4 77.6 0.665
race 0.469
African-American (%) 51.3 58.0
Other (%) 3.2 3.4
White (%) 45.5 38.6
Age ,0.001
65–69 years (%) 37.0 25.5
70–74 years (%) 27.6 18.4
75–79 years (%) 18.2 25.5
80+ years (%) 17.2 30.6
Diabetes (%) 58.2 55.1 0.556
CAD (%) 38.0 38.8 0.887
ChF (%) 31.4 42.9 0.023
stroke (%) 31.4 35.7 0.392
Cancer (%) 28.6 24.5 0.395
COPD (%) 31.2 32.6 0.767
Depression (%) 82.4 73.5 0.032
Dementia (%) 12.2 23.5 0.002
renal disease (%) 19.7 20.4 0.862
Arthritis (%) 8.3 3.1 0.071
Mean baseline PhQ-9 (%) 5.5 (5.1) 4.4 (4.8) 0.025
Abbreviations: PhQ-9, patient health questionnaire-9; CAD, coronary artery disease; 
ChF, congestive heart failure; COPD, chronic obstructive pulmonary disease.
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Table 2 Association of baseline PhQ-9 score with demographics and comorbid conditions (n=773)
Characteristic % PHQ-9 (0–4) % PHQ-9 (5–9) % PHQ-9 ($10) P-value
Overall (n=773) 51.9 27.8 20.3
gender ,0.001
Male (n=159) 63.5 26.4 10.1
Female (n=614) 48.9 28.2 23.0
race 0.045
Black (n=357) 57.4 25.6 16.8
Other (n=22) 31.8 45.4 22.7
White (n=317) 49.5 26.5 24.0
Age ,0.001
65–69 years (n=286) 42.5 28.9 18.3
70–74 years (n=213) 56.4 26.3 10.2
75–79 years (n=141) 66.1 23.7 5.1
80+ years (n=133) 67.0 23.9 6.7
Diabetes 0.766
no (n=323) 51.4 29.1 19.5
Yes (n=450) 52.2 26.9 20.9
CAD 0.915
no (n=479) 52.2 28.0 19.8
Yes (n=294) 51.4 27.6 21.1
ChF 0.100
no (n=530) 54.3 27.0 18.7
Yes (n=243) 46.5 29.6 23.9
stroke 0.986
no (n=530) 52.1 27.7 20.2
Yes (n=243) 51.4 28.0 20.6
Cancer 0.395
no (n=552) 53.1 26.4 20.5
Yes (n=221) 48.9 31.2 19.9
COPD 0.027
no (n=532) 55.1 25.6 19.4
Yes (n=241) 44.8 32.8 22.4
Depression ,0.001
no (n=136) 71.3 23.5 5.2
Yes (n=637) 47.7 28.7 23.6
Dementia 0.038
no (n=679) 50.4 28.1 21.5
Yes (n=94) 62.8 25.5 11.7
renal disease 0.336
no (n=621) 51.2 28.8 20.0
Yes (n=152) 54.6 23.7 21.7
Arthritis 0.525
no (n=709) 52.5 27.5 20.2
Yes (n=64) 45.3 32.8 21.9
Antidepressant ,0.001
no (n=228) 64.5 25.4 10.1
Yes (n=552) 45.8 28.9 25.3
Care provider type at initial visit 0.801
CCA (%) 98.2 98.1 96.8
nP (%) 0.8 0.9 1.9
sW (%) 1.0 0.9 1.3
Care provider type at patients’ subsequent visits
CCA (%) 99.7 99.1 98.7 0.329
nP (%) 2.3 4.3 11.2 ,0.001
rn (%) 0.3 0.0 0.7 0.486
sW (%) 1.5 2.4 9.9 ,0.001
Abbreviations: CCA, care coordinator assistant; nP, nurse practitioner; rn, registered nurse; sW, social worker; PhQ-9, patient health questionnaire-9; CAD, coronary 
artery disease; ChF, congestive heart failure; COPD, chronic obstructive pulmonary disease.
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Table 3 presents mixed model results with factors associ-
ated with PHQ-9 change scores over time in the three patient 
groups defined by baseline PHQ-9 scores. A decreased PHQ-9 
change score indicates clinical improvement, whereas an 
increased PHQ-9 change score indicates a worsening of clini-
cal symptoms. Among those with baseline PHQ-9 scores $10, 
there was a significant decrease in PHQ-9 scores over time 
(P,0.001); however, the effect differed by gender (P=0.015). 
Figure 1 displays the predicted mean PHQ-9 change scores over 
time in both men and women. On average, women’s scores 
(4.5 point drop at 1 month) improved faster than men’s scores 
(1 point drop at 1 month). However, both men and women 
had a predicted drop of 7 points on the PHQ-9 at 6 months. 
At 12 months, men had on an average predicted drop on the 
PHQ-9 of 7 points while women experienced a predicted drop 
of 8 points. A 7-point decline is slightly .50% decline from the 
baseline average PHQ-9 score of 13.6 points for this stratum. 
Among those with baseline PHQ-9 scores of 5–9, changes 
in PHQ-9 scores over time differed by history of CHF 
(P=0.010). In patients without CHF, predicted PHQ-9 scores 
were ~1 point less than those with CHF. However, over time 
the PHQ-9 score remained relatively consistent in those with 
CHF while those without CHF continued to have improving 
PHQ-9 change scores over time. At 12 months, the predicted 
PHQ-9 change scores of patients without CHF were ~1 point 
higher than those with CHF. Use of an antidepressant was 
associated with lower PHQ-9 changes, but this effect did not 
vary over time (Figure 2). 
Finally, among those with initial PHQ-9 scores from 
0 to 4, no significant change in PHQ-9 scores was seen for 
patients without CHF (P=0.958), but CHF affected patient’s 
PHQ-9 response over time. For patients with and without 
CHF, the predicted PHQ-9 change score was -0.5 (an average 
increase of 0.5 points from baseline). For patients without 
CHF, the change score remained relatively constant over 
time (P=0.958), while patients with CHF showed improve-
ment over time with ~0.5 points drop in PHQ-9 scores at 
12 months (Figure 3).
Discussion
Results of the present analyses provide evidence for the 
effectiveness of the ABC Medical Home program at treating 
depressive symptoms in older adults as measured by PHQ-9. 
Depression response in the program is greatest among those 
patients who have the highest initial burden of symptoms and 
is similar in direction and magnitude to the effects seen in 
the earlier randomized control trial upon which this interven-
tion was based.9 Unlike the original control trial however, 
the present program utilized services provided by CCAs and 
nurses, rather than psychologists and nurses, as a means of 
facilitating the program’s reach to the community’s large 
population of seniors. Interventions such as these provide 
initial evidence that effective care for geriatric syndromes 
can be provided in innovative ways utilizing team members 
who require less formal training than previous models.
Targeting of patients in a clinical intervention allows care 
providers to achieve efficiency, identifying those persons who 
are most likely to benefit from the program. In this program, 
discernable patterns of response to the intervention were 
identifiable. The highest response to treatment over time was 
observed among men and women who had the highest initial 
PHQ-9 scores with .50% decline in PHQ-9 score among 
these patients at 6 months, although women’s responses to the 
intervention occurred more quickly than men’s responses. 
The present work stands in contrast to a previous report that 
women with higher severity of depression had a decreased 
response to cognitive behavioral therapy as compared to 
men, though the mechanism by which this occurs is yet to be 
fully elucidated.20 The effect of CHF on patients’ response 
to the intervention was inconsistent among patients with 
different initial PHQ-9 scores. This may reflect differences 
in CHF severity that were not captured when the presence 
or absence of this condition was recorded. The observation 
that PHQ-9 scores remained low and did not appreciably 
increase among those subjects who had low PHQ-9 scores 
at their initial assessment was encouraging.
In the ABC Medical Home program, the majority of 
patient contacts were established by CCAs, rather than 
psychologists or nurses who provided the majority of the 
Table 3 Mixed model results for PhQ-9 change over time
Baseline PHQ-9 Estimate (SE)  
(Regression (beta) coefficient)
P-value
$10
Time 2.152 (0.503) ,0.001
Time squared -0.124 (0.038) 0.001
Any stroke -1.493 (0.773) 0.055
Female 5.264 (1.891) 0.006
Female × time -1.513 (0.535) 0.005
Female × time squared 0.100 (0.041) 0.015
5–9
Time 0.210 (0.039) ,0.001
Antidepressants -1.186 (0.419) 0.005
ChF 1.146 (0.522) 0.029
ChF × time -0.167 (0.065) 0.010
0–4
Time -0.034 (0.020) 0.090
ChF -0.270 (0.308) 0.381
ChF × time 0.120 (0.036) 0.001
Abbreviations: PhQ-9, patient health questionnaire-9; se, standard error; ChF, 
congestive heart failure.
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Figure 1 Predicted PhQ-9 change* from mixed effects model for baseline PhQ-9 (10+).
Note: *Increase change score = decrease in PhQ-9 (improving symptoms).
Abbreviation: PhQ-9, patient health questionnaire-9.
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Figure 2 Predicted PhQ-9 change from mixed effects model for baseline PhQ-9 (5–9).
Abbreviations: PhQ-9, patient health questionnaire-9; ChF, congestive heart failure.
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intervention in the original IMPACT clinical trial. Nurses or 
social workers were most commonly involved directly in the 
care of patients whose PHQ-9 scores were the highest. While 
the cost savings for the present program is not reported and 
a separate financial analysis of this program’s cost saving 
will be calculated in a separate independent analysis, the fact 
that the majority of the program’s depression intervention is 
provided by team members without a professional medical or 
health degree is encouraging. This has important implications 
for the provision of care to the increasing number of older 
adults as the country must develop a geriatric mental health 
workforce to care for this population.21–23 
limitations
This work has several limitations worth noting. First, the out-
comes of a clinical program being administered in a health 
care system over time have been reported, rather than the 
results of a randomized trial conducted under static condi-
tions. Second, some patients who had low-level depressive 
symptoms were enrolled in the program. As depression is 
a cyclical illness, patients with low-level depressive symp-
toms were recognized as being at risk of recurrence of 
their depression and offered relapse prevention activities. 
Additional information on psychiatric comorbidities beyond 
depression is unavailable and the effect of these condi-
tions on patient response is unknown. Third, as this is an 
implementation program, there was no natural comparison 
group to study depression response among patients who did 
not receive the intervention. Still, this program is rooted in 
models of care that have been shown to be efficacious in 
earlier randomized controlled trials and the direction and 
magnitude of patient response are similar to the original 
clinical trial. Fourth, given that patient assessments were 
obtained by the same staff who were providing the clinical 
intervention, it is possible that an assessment bias could 
have been introduced into this work. Finally, as a popula-
tion health management program, not all 1,621 patients who 
were enrolled in this program’s registry were able to be seen 
and patients whom the clinical team were able to contact 
may differ from patients who could not be contacted, as 
discussed previously.13
Conclusion
The present analyses provide initial evidence for the sus-
tained effectiveness of the ABC Medical Home program 
at inducing depression remission, as measured by .50% 
decline in PHQ-9 scores among those with initial scores $10, 
and achieving relapse prevention, averting an increase in 
depressive symptoms among patients with low PHQ-9 
scores. In achieving these outcomes, the program employed 
clinical staff who required less formal training than those 
employed in earlier randomized trials. As such, this program 
provides a potential model for the expansion of the workforce 
of professionals trained in mental health to meet the needs 
of a growing population of older adults.
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